Page 1 of 1

#1

Posted: Fri Jun 26, 2026 9:38 pm
by RSS Post Bot
Researchers found that a rare liver cancer evades immunotherapy by luring immune T cells away from the tumor and trapping them in nearby fibrous tissue. An FDA-approved drug called AMD3100 freed those T cells to attack the cancer, significantly improving the effectiveness of immunotherapy in tumor samples.

Source: https://www.sciencedaily.com/releases/2 ... 014014.htm